From the Departments of Neurological Surgery (K.J., S.A., D.K., G.L., A.F., R.H., D.K., N.H., D.A.).
Epidemiology & Population Health (J.Q., W.M.), Montefiore Medical Center, Bronx, New York.
AJNR Am J Neuroradiol. 2023 May;44(5):574-579. doi: 10.3174/ajnr.A7856. Epub 2023 Apr 27.
Intracranial aneurysms have a reported prevalence of 1%-2% in the general population. Currently, only patients with a strong family history or autosomal dominant polycystic kidney disease are screened for intracranial aneurysms using MRA. The purpose of this study was to determine whether there are other specific patient populations at risk that should be offered screening for intracranial aneurysms.
This is a retrospective case-control study of adult patients who underwent a screening MRA of their brain at our comprehensive stroke center from 2011 to 2020. Patients with a history of a known brain aneurysm were excluded. Data were extracted on patient demographics and medical comorbidities. Bivariate analyses were performed, followed by multivariable logistic regression, to identify factors associated with a positive MRA screen for incidental aneurysms.
Of 24,397 patients eligible for this study, 2084 screened positive for a possible intracranial aneurysm. On bivariate analysis, significant differences were present in the following categories: age, sex, race and ethnicity, chronic constipation, and hyperlipidemia. On logistic regression analysis, older age (+10 years: OR = 10.01; 95% CI, 10.01-10.02; = .001), female sex (OR = 1.37; 95% CI, 1.24-1.51; = .001), non-Hispanic Black (OR = 1.19; 95% CI, 1.02-1.40; = .031), and Hispanic ethnicity (OR = 1.35; 95% CI, 1.16-1.58; = .001) versus non-Hispanic White remained significant when adjusted for other factors.
Targeted screening for high-risk elderly women of Black or Hispanic descent will yield higher positive findings for brain aneurysms, which may mitigate the risk of rupture. Whether this is a cost-effective approach has yet to be determined.
颅内动脉瘤在普通人群中的发病率为 1%-2%。目前,只有有强烈家族史或常染色体显性多囊肾病的患者才会使用 MRA 筛查颅内动脉瘤。本研究旨在确定是否存在其他具有颅内动脉瘤风险的特定患者群体,需要对其进行筛查。
这是一项回顾性病例对照研究,纳入了 2011 年至 2020 年期间在我们的综合卒中中心进行脑 MRA 筛查的成年患者。排除有已知脑动脉瘤病史的患者。提取患者的人口统计学和合并症数据。进行了单变量分析,随后进行多变量逻辑回归,以确定与偶然发现的颅内动脉瘤阳性 MRA 筛查相关的因素。
在 24397 名符合条件的患者中,有 2084 名患者的 MRA 筛查结果显示可能存在颅内动脉瘤。在单变量分析中,以下几类存在显著差异:年龄、性别、种族和民族、慢性便秘和高血脂。在逻辑回归分析中,年龄每增加 10 岁(比值比[OR] = 10.01;95%置信区间[CI],10.01-10.02;P < 0.001)、女性(OR = 1.37;95% CI,1.24-1.51;P < 0.001)、非西班牙裔黑人(OR = 1.19;95% CI,1.02-1.40;P = 0.031)和西班牙裔(OR = 1.35;95% CI,1.16-1.58;P < 0.001)与非西班牙裔白人相比,在调整其他因素后仍具有统计学意义。
针对高危老年女性(黑人或西班牙裔)进行靶向筛查将发现更多的脑动脉瘤阳性结果,这可能降低破裂风险。但这种方法是否具有成本效益仍有待确定。